Publication
Neoadjuvant triplet chemotherapy enables radiotherapy avoidance in human papillomavirus-associated oropharyngeal cancer: a multicentre Phase II trial.
Tomoya Yokota, Toyonori Tsuzuki, Tetsuro Onitsuka, Akira Iizuka, Yohei Ouchi, Terushige Mori, Kiyoaki Tsukahara, Kenji Hanyu, Takashi Mukaigawa, Torahiko Nakashima, Hideoki Uryu, Go Omura, Hiromu Nakamura, Hirokazu Uemura, Daisuke Nishikawa, Satoshi Kano, Yasuto Akiyama, Tsuyoshi Onoe, Shunsuke Oyamada, Takuhiro Yamaguchi
- Source
- PubMed
- Retrieved
- Sep 30, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20260930-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
BACKGROUND: This prospective Phase 2 trial assessed a novel de-escalation strategy for upfront neoadjuvant chemotherapy with docetaxel, cisplatin, and 5-fluorouracil (NAC-TPF) to avoid postoperative radiotherapy (PORT) and chemoradiotherapy (POCRT) for human papillomavirus (HPV)-associated…
Read on PubMedLinked entities
Linked entities (1)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Candidate 1
- cancerMalignant Oropharyngeal Neoplasmdictionary0.60
Curated evidence
Evidence citing this paper (0)
Data not yet available